Association between human herpesvirus-6 and primary brain tumors: a systematic review and meta-analysis

References

• 1. Nanthagopal AP, Rajamony RS. Classification of benign and malignant brain tumor CT images using wavelet texture parameters and neural network classifier. J. Vis. 16(1), 19–28 (2013).
  Google Scholar
• 2. Barnholtz-Sloan JS. Brain and central nervous system tumor statistics: access to accurate data for all countries is critical. Neuro-Oncol. 21(3), 291–292 (2019).
  MedlineGoogle Scholar
• 3. Liu J, Wang L. Primary and secondary gliosarcomas: a review of clinical features and pathological diagnosis. Am. J. Clin. Oncol. 36(15), e14043–e14043 (2018).
  Google Scholar
• 4. Jiang Y, Uhrbom L. On the origin of glioma. Ups. J. Med. Sci. 117(2), 113–121 (2012).
  MedlineGoogle Scholar
• 5. Goodenberger M, Jenkins R. Genetics of adult glioma. Cancer Genet. 205, 613–621 (2012).
  MedlineGoogle Scholar
• 6. Thakkar P, Greenwald BD, Patel P. Rehabilitation of adult patients with primary brain tumors: a narrative review. Brain Sci. 10(8), 492 (2020).
  CASGoogle Scholar
• 7. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10), 2698–2705 (2002).
  MedlineGoogle Scholar
• 8. Perkins A, Liu G. Primary brain tumors in adults: diagnosis and treatment. Am. Fam. Physician 93(3), 211–217 (2016).
  MedlineGoogle Scholar
• 9. Ostrom QT, Haley Gittleman M, Gabrielle Truitt M, Alexander Boscia B, Carol Kruchko B, Jill S. Barnholtz-Sloan BA. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncol. 20(Suppl. 4), iv1–iv86 (2018).
  MedlineGoogle Scholar
• 10. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 69(1), 7–34 (2019).
  MedlineGoogle Scholar
• 11. Elchoufi D, Duszak R, Balthazar P, Hanna TN, Sadigh G. Increasing emergency department utilization of brain imaging in patients with primary brain cancer. Emerg. Radiol. 28(2), 223–231 (2020).
  MedlineGoogle Scholar
• 12. Siegel RL, Miller KD, Goding Sauer A et al. Colorectal cancer statistics, 2020. CA Cancer J. Clin. 70(3), 145–164 (2020).
  MedlineGoogle Scholar
• 13. Bolt HM. Vinyl chloride – a classical industrial toxicant of new interest. Crit. Rev. Toxicol. 35(4), 307–323 (2005).
  Medline CASGoogle Scholar
• 14. Bleeker FE, Hopman SM, Merks JH, Aalfs CM, Hennekam RC. Brain tumors and syndromes in children. Neuropediatrics 45(3), 137–161 (2014).
  MedlineGoogle Scholar
• 15. Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K. Epstein–Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time? Brain Tumor Pathol. 28(2), 145–149 (2011).
  MedlineGoogle Scholar
• 16. Dahlborg SA, Henner WD, Crossen JR et al. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J. Sci. Am. 2(3), 166–174 (1996).
  Medline CASGoogle Scholar
• 17. Fozuni E, Mollaei HR, Iranpour M, Afshar RM. Evaluation frequency of human herpes virus type 8 in patients with breast cancer. Res. Square doi:10.21203/rs.3.rs-60897/v1 (2020) (Epub ahead of print).
  Google Scholar
• 18. Eliassen E, Lum E, Pritchett J et al. Human herpesvirus 6 and malignancy: a review. Front. Oncol. 8, 512 (2018).
  MedlineGoogle Scholar
• 19. Mirzaei H, Ghorbani S, Khanizadeh S, Namdari H, Faghihloo E, Akbari A. Histone deacetylases in virus-associated cancers. Rev. Med. Virol. 30(1), e2085 (2020).
  MedlineGoogle Scholar
• 20. Liu X, Liu J, Qiu H et al. Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis. BMC Cancer 15(1), 1–9 (2015).
  MedlineGoogle Scholar
• 21. Moghoofei M, Mostafaei S, Nesaei A et al. Epstein–Barr virus and thyroid cancer: the role of viral expressed proteins. J. Cell. Physiol. 234(4), 3790–3799 (2019).
  Medline CASGoogle Scholar
• 22. Moghoofei M, Keshavarz M, Ghorbani S et al. Association between human papillomavirus infection and prostate cancer: a global systematic review and meta-analysis. Asia Pac. J. Clin. Oncol. 15(5), e59–e67 (2019).
  MedlineGoogle Scholar
• 23. Leibovitch EC, Almira-Suarez MI, Jacobson S. Human herpesvirus multiplex ddPCR detection in brain tissue from low-and high-grade astrocytoma cases and controls. Infect. Agents Cancer 11(1), 1–10 (2016).
  MedlineGoogle Scholar
• 24. Farias KP, Moreli ML, Floriano VG, Da Costa VG. Evidence based on a meta-analysis of human cytomegalovirus infection in glioma. Arch. Virol. 164(5), 1249–1257 (2019).
  Medline CASGoogle Scholar
• 25. Wells MJ, Jacobson S, Levine PH. An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity. Infect. Agents Cancer 14(1), 1–12 (2019).
  MedlineGoogle Scholar
• 26. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 18(1), 217–245 (2005).
  MedlineGoogle Scholar
• 27. Chi J, Gu B, Zhang C et al. Human herpesvirus 6 latent infection in patients with glioma. J. Infect. Dis. 206(9), 1394–1398 (2012).
  Medline CASGoogle Scholar
• 28. Reynaud JM, Horvat B. Human herpesvirus 6 and neuroinflammation. Int. Sch. Res. Notices 2013, (2013).
  Google Scholar
• 29. Crawford JR, Santi MR, Cornelison R, Sallinen SL, Haapasalo H, Macdonald TJ. Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors. J. Neuro-Oncol. 95(1), 49–60 (2009).
  Medline CASGoogle Scholar
• 30. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7), e1000097 (2009).
  MedlineGoogle Scholar
• 31. Crawford JR, Santi MR, Thorarinsdottir HK et al. Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J. Clin. Virol. 46(1), 37–42 (2009).
  Medline CASGoogle Scholar
• 32. Zheng X, Li S, Zang Z et al. Evidence for possible role of toll-like receptor 3 mediating virus-induced progression of pituitary adenomas. Mol. Cell. Endocrinol. 426, 22–32 (2016).
  Medline CASGoogle Scholar
• 33. Cuomo L, Trivedi P, Cardillo MR et al. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J. Med. Virol. 63(1), 45–51 (2001).
  Medline CASGoogle Scholar
• 34. Gu B, Li M, Zhang Y, Li L, Yao K, Wang S. DR7 encoded by human herpesvirus 6 promotes glioma development and progression. Cancer Manag. Res. 11, 2109 (2019).
  Medline CASGoogle Scholar
• 35. Cantalupo PG, Katz JP, Pipas JM. Viral sequences in human cancer. Virology 513, 208–216 (2018).
  Medline CASGoogle Scholar
• 36. Cao S, Wendl MC, Wyczalkowski MA et al. Divergent viral presentation among human tumors and adjacent normal tissues. Sci. Rep. 6(1), 1–12 (2016).
  Medline CASGoogle Scholar
• 37. Chan P, Ng H, Cheng A. Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours. J. Clin. Pathol. 52(8), 620–623 (1999).
  Medline CASGoogle Scholar
• 38. Mayerava V, Srukalova I, Gapeenko H, Viluga A, Smolyakova R, Grachev Y. Detection of molecular-genetic and immunological markers of herpes viruses in patients with a primary brain tumor. (2017).
  Google Scholar
• 39. Paulus W, Jellinger K, Hallas C, Ott G, Müller-Hermelink H. Human herpesvirus-6 and Epstein–Barr virus genome in primary cerebral lymphomas. Neurology 43(8), 1591–1591 (1993).
  Medline CASGoogle Scholar
• 40. Strojnik T, Duh D, Lah TT. Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential. In Vivo 31(2), 221–229 (2017).
  Medline CASGoogle Scholar
• 41. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurotherapeutics 6(3), 427–435 (2009).
  Medline CASGoogle Scholar
• 42. Zerr DM, Meier AS, Selke SS et al. A population-based study of primary human herpesvirus 6 infection. N. Engl. J. Med. 352(8), 768–776 (2005).
  Medline CASGoogle Scholar
• 43. Mordenti P, Zaffignani E, Immovilli P, Nobili E, Cavanna L. Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer. Chemotherapy 59(5), 385–386 (2013).
  Medline CASGoogle Scholar
• 44. Pormohammad A, Azimi T, Falah F, Faghihloo E. Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta-analysis. J. Cell. Physiol. 233(4), 2850–2862 (2018).
  Medline CASGoogle Scholar
• 45. Laina I, Syriopoulou VP, Daikos GL et al. Febrile seizures and primary human herpesvirus 6 infection. Pediatr. Neurol. 42(1), 28–31 (2010).
  MedlineGoogle Scholar
• 46. Kashanchi F, Araujo J, Doniger J et al. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14(3), 359–367 (1997).
  Medline CASGoogle Scholar
• 47. Lacroix A, Collot-Teixeira S, Mardivirin L et al. Involvement of human herpesvirus-6 variant B in classic Hodgkin's lymphoma via DR7 oncoprotein. Clin. Cancer Res. 16(19), 4711–4721 (2010).
  Medline CASGoogle Scholar
• 48. Siddon A, Lozovatsky L, Mohamed A, Hudnall SD. Human herpesvirus 6 positive Reed–Sternberg cells in nodular sclerosis Hodgkin lymphoma. Br. J. Haematol. 158(5), 635–643 (2012).
  MedlineGoogle Scholar
• 49. Takemoto M, Mori Y, Ueda K, Kondo K, Yamanishi K. Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J. Gen. Virol. 85(4), 869–879 (2004).
  Medline CASGoogle Scholar